Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03793231Unknown

fungalAi for Fungal Surveillance & Antifungal Stewardship

Role: collaborator

NCT01418131Phase 4Completed

Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis

Role: collaborator

NCT01631708Not ApplicableCompleted

Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?

Role: collaborator

NCT01726400Completed

In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia

Role: lead

NCT00750763Phase 4Completed

Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy

Role: lead

NCT00288834Not ApplicableCompleted

Outcomes of Swallowing Rehabilitation After Stroke

Role: collaborator

All 6 trials loaded